SCHEMBL6557378

SCHEMBL6557378

CN(C)CCc1ccc(Br)cc1NC(=O)C(F)(F)F

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.38
TAAR1 Q96RJ0 3/20 0.37
PDK1 Q15118 1/20 0.37
PDK2 Q15119 1/20 0.37
PDK3 Q15120 1/20 0.37
PDK4 Q16654 1/20 0.37
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 2/20 0.37
CHEK1 O14757 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
ALOX12 P18054 1/20 0.36
HRH3 Q9Y5N1 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
THRB P10828 1/20 0.34
LMNA P02545 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27496539 0.86 SLC6A4 (0.41) CYP1A2PDK1PDK2PDK3PDK4
SCHEMBL17351215 0.80 MAPT (0.36) CYP1A2MAPTL3MBTL1LMNACYP2C9
SCHEMBL20749950 0.75 MAPK1 (0.50) CYP1A2ALDH1A1MAPTL3MBTL1CYP2C9
SCHEMBL3543982 0.74 ALDH1A1 (0.43) CYP1A2PDK1PDK2PDK3PDK4
SCHEMBL6555370 0.73 LMNA (0.44) ALDH1A1MAPTALOX12LMNA
SCHEMBL31283238 0.73 KCNK2 (0.46) CYP1A2ALDH1A1MAPTL3MBTL1LMNA
SCHEMBL24251938 0.72 MEN1 (0.47) CYP1A2MAPTHPGDL3MBTL1LMNA
SCHEMBL3441761 0.72 ALDH1A1 (0.42) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL3529995 0.72 MAPK1 (0.39) ALDH1A1KDM4EMAPTL3MBTL1LMNA
SCHEMBL29977168 0.72 PDK1 (0.46) CYP1A2PDK1PDK2PDK3PDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1230224-B1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2004-12-29 EP disclosed
US-6821980-B1 Substituted 5-benzyl-2,4-diaminopyrimidines BASILEA PHARMACEUTICA AG (CH) 2004-11-23 US disclosed
EP-1230224-A1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES F. HOFFMANN-LA ROCHE AG (CH) 2002-08-14 EP disclosed
WO-2001032633-A1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2001-05-10 WO disclosed